SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks. Loyola-Velez AJ, John BV. Dig Dis Sci 2024 Nov 24. doi: 10.1007/s10620-024-08703.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Loyola-Velez AJ, John BV. SGLT2 Inhibitors in Cirrhosis: A Promising Therapeutic Avenue with Potential Risks. Dig Dis Sci 2024 Nov 24. doi: 10.1007/s10620-024-08703.
PMID: 39581899